Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Lee’s Pharm Signs $78.9 Million Deal for RDS Drug/Device for Pre-Term Infants

publication date: Aug 24, 2022

Lee's Pharm of Hong Kong entered a $78.9 million deal with Windtree Therapeutics for global rights to a therapy for respiratory distress syndrome in pre-term infants. The therapy includes Surfaxin®, a lyophilized lucinactant, and the AeroSurf non-invasive drug/device. Lee’s, which had previously acquired China rights to the therapy, will be fully responsible for all costs of global development. There is no additional upfront payment, but Lee’s will pay up to $78.9 million in milestones, plus royalties on sales. RDS often occurs in preterm infants if the lung is not fully developed with natural surfactant. More details....

Stock Symbol:  (HK: 0950)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here